Search Within

James Joseph Harding

Formats
  1. Meeting Abstract (128)
  2. Journal Article (118)
  3. Review (7)
  4. Book Section (3)
  5. Miscellaneous (3)
  6. Editorial (1)
Groups
  1. Department of Medicine (260)
  2. Gastrointestinal Oncology Service (260)
  3. Solid Tumor Oncology Division (260)
  4. Center for Pancreatic Cancer Research (135)
  5. GSK Faculty (102)
  6. Epidemiology and Biostatistics (92)

More Groups

People
  1. Ghassan Abou-Alfa (135)
  2. Eileen O'Reilly (74)
  3. William Jarnagin (60)
  4. Michael Berger (40)
  5. Michael D'Angelica (40)
  6. Andrea Cercek Hanjis (39)

More People

Years
  1. 2025 (21)
  2. 2024 (32)
  3. 2023 (34)
  4. 2022 (21)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (89)
  2. Annals of Oncology (20)
  3. Clinical Cancer Research (15)
  4. Annals of Surgical Oncology (13)
  5. JCO Precision Oncology (10)
  6. Cancer (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (102)
  2. Oxford University Press (28)
  3. American Association for Cancer Research (23)
  4. Springer (21)
  5. Wiley Blackwell (14)
  6. Elsevier Science, Inc. (10)

More Publishers

Results (260)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS) in combination with paclitaxel (Pac) in patients (pts) with triple negative breast cancer (TNBC)
    Meeting Abstract

    DeMichele, A.; Harding, J. J.; Telli, M. L.; Munster, P. N.; McKay, R.; Iliopoulos, O.; Orford, K. W.; Bennett, M. K.; Mier, J. W.; Owonikoko, T. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance)
    Meeting Abstract

    Abou-Alfa, G. K.; Niedzwieski, D.; Knox, J. J.; Kaubisch, A.; Posey, J.; Tan, B. R.; Kavan, P.; Goel, R.; Lammers, P. E.; Bekaii-Saab, T. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Detection of IDH1 mutations in circulating free DNA in patients with cholangiocarcinoma
    Meeting Abstract

    Lowery, M. A.; You, D.; Samoila, A.; Peerschke, E.; Viale, A.; Patel, R.; Selcuklu, D.; Rusek, M.; Cercek, A.; Kemeny, N.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)
    Meeting Abstract

    Meric-Bernstam, F.; Tannir, N.; Harding, J.; Voss, M.; Mier, J.; DeMichele, A.; Munster, P.; Patel, M.; Iliopoulos, O.; Owonikoko, T.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Advances in cholangiocarcinoma research: Report from the third cholangiocarcinoma foundation annual conference
    Journal Article

    Abou-Alfa, G. K.; Andersen, J. B.; Chapman, W.; Choti, M.; Forbes, S. J.; Gores, G. J.; Hong, T. S.; Harding, J. J.; Vander Heiden, M. G.; Javle, M.; more...
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma
    Journal Article

    Connell, L. C.; Harding, J. J.; Shia, J.; Abou-Alfa, G. K.
    Chinese Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Acute myeloid leukemia masquerading as hepatocellular carcinoma
    Journal Article

    Abu-Zeinah, G. F.; Weisman, P.; Ganesh, K.; Katz, S. S.; Dogan, A.; Abou-Alfa, G. K.; Stein, E. M.; Jarnagin, W.; Mauro, M. J.; Harding, J. J.
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis
    Meeting Abstract

    Lowery, M. A.; Goff, L. W.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O'Reilly, E. M.; Harding, J. J.; Kemeny, N. E.; Capanu, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Emibetuzumab plus ramucirumab: Simultaneous targeting of MET and VEGFR-2 in patients with advanced hepatocellular cancer in a phase 1b/2 study
    Meeting Abstract

    Harding, J. J.; Bendell, J. C.; Fuchs, C. S.; Wang, X. J.; Wacheck, V.; Zhu, A. X.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Advanced hepatocellular cancer: The current state of future research
    Journal Article

    Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.
    Current Treatment Options in Oncology (2016)

    Fulltext@MSK | Save